Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

La sténose cervicale affecte-t-elle la fonction de la main ?

2 novembre 2026 mis à jour par: Kadir Songur, Izmir Democracy University

Le degré de sténose spinale cervicale affecte-t-il la fonction de la main ?

The cervical spine is a complex structure that supports the weight of the head and protects the spinal cord and nerve roots. Cervical spinal stenosis (CSS), which develops as a result of degenerative processes, can cause narrowing of the spinal canal and compression of nerve structures, leading to symptoms such as pain, numbness, and weakness. This condition can negatively affect hand function, particularly grip strength and dexterity. However, studies in the literature examining the effect of CSS on grip strength and hand function are limited. Therefore, this study will be conducted to determine the effect of the severity of cervical spinal stenosis, identified in patients who underwent MRI following their presentation with cervical problems at the Physical Medicine and Rehabilitation outpatient clinic of Buca Seyfi Demirsoy Training and Research Hospital, İzmir Democracy University, on hand grip strength and functionality. Grip strength will be assessed using the Jamar hand dynamometer, and fine pinch strength will be evaluated using the Lafayette pinch meter. Additionally, hand functionality will be measured using the Nine-Hole Peg Test. The impact of neck pain on daily life will be assessed using the Neck Disability Index. The data obtained will be compared and analyzed using appropriate statistical methods.

This study is expected to fill a significant gap in the current literature by comprehensively elucidating the effects of cervical stenosis on hand function and grip performance, thereby contributing to the individualization of rehabilitation approaches.

Aperçu de l'étude

Type d'étude

Observationnel

Inscription (Réel)

186

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 75 ans (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

The sample for this study will consist of individuals who presented to the Physical Medicine and Rehabilitation outpatient clinic at the Buca Seyfi Demirsoy Training and Research Hospital of Izmir Democracy University due to cervical problems and underwent cervical MRI. After obtaining informed consent, the individuals included in the study will undergo evaluation. First, participants will be grouped based on their cervical stenosis scores. The degree of cervical stenosis will be determined using MRIs that were previously requested and performed during various outpatient services. The evaluation of the MRI will be scored according to the Kang grading system for spinal stenosis. The Kang grading system includes four degrees ranging from 0 to 3 based on spinal cord compression.

La description

Inclusion Criteria:

  • Individuals aged 18-75
  • Individuals who have previously undergone a cervical MRI
  • Cases where the degree of stenosis can be clearly determined on MRI
  • Individuals who have had neck pain for at least 3 months

Exclusion Criteria:

  • Individuals who declined to participate in the study
  • Individuals who had undergone cervical surgery
  • Individuals diagnosed with vertigo
  • Individuals with sudden hearing loss
  • Individuals with additional neurological conditions
  • Individuals with psychiatric or cognitive disorders that would prevent measurement in the study

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Modèles d'observation: CASE_ONLY
  • Perspectives temporelles: CROSS_SECTIONAL

Cohortes et interventions

Groupe / Cohorte
1

Group with Kang grade 0

2

Group with Kang grade 1

3

Group with Kang grade 2

4

Group with Kang grade 3

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Hand Grip Strength
Délai: Day 1

Hand grip strength will be assessed using a Jamar hydraulic hand dynamometer. Measurements will be taken while seated, with the arm positioned as follows: shoulder adduction, elbow at 90° flexion, and forearm in a neutral position. The wrist will be positioned at 0-30° extension and 0-15° ulnar deviation. The volunteer will be asked to grip the dynamometer firmly and squeeze as hard as possible. The measurements will be repeated three times, and the average value will be recorded in kilograms.

Day 1

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Pinch Strength
Délai: Day 1

A Lafayette brand hydraulic pinch meter will be used for this measurement. Measurements will be taken in three ways: two-point, lateral, and three-point grips. For the two-point grip measurement, the subject will be asked to squeeze the pinch meter using the tips of their thumb and index finger. For the lateral grip measurement, the volunteer will be asked to squeeze the pinch meter using the middle of the distal phalanx of the thumb and the lateral part of the middle phalanx of the index finger. For the three-point grip measurement, the subject will be instructed to squeeze the pinch meter using the distal phalanges of the thumb, index finger, and middle finger. Measurements will be taken in the same position as the grip strength test, in accordance with the standard; three measurements will be taken for each grip type, and the average will be recorded in pounds (lb).

Day 1
The Nine-Hole Peg Test
Délai: Day 1

The participants' manual dexterity will be assessed using the Nine-Hole Peg Test, which has been proven to be valid and reliable. The test consists of nine identical holes spaced at equal intervals and nine matching pegs. The timer starts the moment the person first touches a peg to place it. The person will be asked to take the pegs from the box, place them in the holes as quickly as possible, and then remove them and return them to the box. The test will be conducted while the person is seated. The activity time will be recorded in seconds.

Day 1
Neck Disability Index
Délai: Day 1

The Neck Disability Index is an adaptation of the Oswestry Disability Index for the cervical region and is a widely used 10-item questionnaire for assessing cervical dysfunction and neck pain. Each item is scored between 0 (no disability) and 5 (complete disability). The total score ranges from 0 to 50; a higher score indicates greater functional limitation. The questionnaire has established validity and reliability in Turkish.

Day 1

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 août 2026

Achèvement primaire (Réel)

1 octobre 2026

Achèvement de l'étude (Réel)

1 novembre 2026

Dates d'inscription aux études

Première soumission

30 mars 2026

Première soumission répondant aux critères de contrôle qualité

30 mars 2026

Première publication (Réel)

6 avril 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

4 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

2 novembre 2026

Dernière vérification

1 mai 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Description du régime IPD

Individual participant data (IPD) will not be shared because the data contain potentially identifiable sensitive clinical information, and sharing was not covered in the original informed consent provided to participants. Additionally, institutional and national data protection regulations limit the transfer of raw, de-identified individual-level data outside the research team.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner